Precision Medicine Approaches for Stratification and Development of Novel Therapies of Latin(x) Patients at Risk of Lung Malignancy
Open Access
- 15 November 2022
- book chapter
- Published by Springer Nature
- p. 89-98
Abstract
Precision medicine has emerged as an optimal health-care delivery platform, which emphasizes integration of individual patient characteristics into patient care. For lung cancer, precision approaches have focused mostly on targeted therapies directed at tyrosine kinases and immunotherapy. It is proposed that refinements should focus on improved risk stratification of patients at heightened risk of lung malignancy, namely patients with chronic obstructive pulmonary disease (COPD). African ancestry is associated with worsened clinical outcomes in COPD and lung cancer, which is relevant for Latinx populations given that varying degrees of African ancestry exist among several Latinx subgroups. The work reviewed here focuses on ORF1p, a protein encoded by Long Interspersed Element-1 (LINE-1) and associated with genetic instability. Because high expression of ORF1p is associated with poor prognosis in patients with non-small-cell lung cancer (NSCLC), it is hypothesized that circulating ORF1p can be monitored as a proxy of genetic instability in patients with COPD and lung cancer. Circulating ORF1p levels correlate with FEV1 deficits and airflow limitation (the hallmark of COPD) in former smokers, and tissue expression of ORF1p is increased in TP53 mutant NSCLC compared to wildtype. Understanding the role of ORF1p in COPD and lung cancer and its utility as a biomarker of genetic instability may lead to advances in lung cancer care and development of novel targeted therapies.Keywords
This publication has 65 references indexed in Scilit:
- Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotranspositionNucleic Acids Research, 2013
- Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer RiskPLOS ONE, 2012
- Genetic Ancestry-Smoking Interactions and Lung Function in African Americans: A Cohort StudyPLOS ONE, 2012
- The Relationship Between Chronic Obstructive Pulmonary Disease and Lung Cancer in African American PatientsClinical Lung Cancer, 2012
- New Mexican Hispanic Smokers Have Lower Odds of Chronic Obstructive Pulmonary Disease and Less Decline in Lung Function Than Non-Hispanic WhitesAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Genetic evidence linking lung cancer and COPD: a new perspectiveThe Application of Clinical Genetics, 2011
- Genetic Ancestry in Lung-Function PredictionsNew England Journal of Medicine, 2010
- LINE-1 Retrotransposition Activity in Human GenomesCell, 2010
- Natural Mutagenesis of Human Genomes by Endogenous RetrotransposonsCell, 2010
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008